Bayer leads Metagenomi complete $65M series A financing round

US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...

November 16, 2020 | Monday | News
Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes

These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...

May 21, 2020 | Thursday | News
Indian Pharma market to raise from US$34.3bn in 2020 to more than US$45bn by 2025

Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...

February 24, 2020 | Monday | News
Towa to acquire Esteve’s generic division for 320M euros

Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...

December 24, 2019 | Tuesday | News
Panacea Biotec launches diabetes drug in India

Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...

December 11, 2019 | Wednesday | News
HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug

The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...

December 6, 2019 | Friday | News
Eris Lifesciences acquires trademark Zomelis from Novartis for India market

Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...

December 4, 2019 | Wednesday | News
EMA and FDA accept marketing applications for Chugai's Satralizumab

Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...

October 31, 2019 | Thursday | News
Dr. Reddy’s confirms recall of all Ranitidine products

Dr. Reddy’s Laboratories along with its subsidiaries, together referred to as “Dr. Reddy’s confirms it...

October 24, 2019 | Thursday | News
Eisai, Nichi-Iko explore generic pharma biz in China

Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...

October 1, 2019 | Tuesday | News
Glenmark receives approval from Russia to market Montlezir

Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...

September 30, 2019 | Monday | News
Glenmark receives Orphan Drug Designation for GBR 1342

Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...

September 17, 2019 | Tuesday | News
Lupin launches antidepressant drug

Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...

August 23, 2019 | Friday | News
Teva launches Epinephrine Injection in the US

Teva Pharmaceutical Industries has announced the availability of the FDA-approved generic version of EpiPen Jr®1&nbs...

August 21, 2019 | Wednesday | News
Sandoz launches oncology generic gefitinib in 13 EU countries

Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...

July 10, 2019 | Wednesday | News
Teva announces launch of a generic version of Tracleer® in US

Teva Pharmaceutical Industries Ltd. has announced the launch of a generic version of Tracleer® (bosentan) tablets, 6...

June 20, 2019 | Thursday | News
Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2)

Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...

June 5, 2019 | Wednesday | News
GSK announces approval of Shingrix in China

GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...

May 27, 2019 | Monday | News